Core Laboratories (CLB) to Release Earnings on Wednesday

Core Laboratories (NYSE:CLB) is expected to post its quarterly earnings results after the market closes on Wednesday, January 29th. Analysts expect Core Laboratories to post earnings of $0.23 per share and revenue of $133,349.57 billion for the quarter. Persons interested in participating in the company’s earnings conference call can do so using this link.

Core Laboratories (NYSE:CLB) last released its quarterly earnings results on Wednesday, October 23rd. The oil and gas company reported $0.25 earnings per share for the quarter, topping analysts’ consensus estimates of $0.21 by $0.04. Core Laboratories had a return on equity of 15.84% and a net margin of 5.83%. The company had revenue of $134.40 million during the quarter, compared to analysts’ expectations of $134.16 million. During the same quarter in the prior year, the firm posted $0.22 EPS. Core Laboratories’s quarterly revenue was up 7.2% compared to the same quarter last year. On average, analysts expect Core Laboratories to post $1 EPS for the current fiscal year and $1 EPS for the next fiscal year.

Core Laboratories Stock Up 3.4 %

Shares of CLB opened at $20.36 on Wednesday. The company has a current ratio of 2.48, a quick ratio of 1.79 and a debt-to-equity ratio of 0.55. The firm has a market cap of $956.09 million, a P/E ratio of 31.33, a PEG ratio of 1.12 and a beta of 2.39. The stock’s 50 day moving average is $19.09 and its two-hundred day moving average is $19.56. Core Laboratories has a 12 month low of $13.82 and a 12 month high of $25.13.

Analyst Ratings Changes

CLB has been the subject of several recent analyst reports. StockNews.com raised shares of Core Laboratories from a “sell” rating to a “hold” rating in a report on Thursday, November 7th. Citigroup cut their target price on shares of Core Laboratories from $15.00 to $14.00 and set a “sell” rating for the company in a research note on Thursday, October 31st. Two equities research analysts have rated the stock with a sell rating and three have given a hold rating to the company’s stock. According to data from MarketBeat.com, the stock presently has a consensus rating of “Hold” and an average price target of $17.00.

About Core Laboratories

Core Laboratories Inc provides reservoir description and production enhancement services and products to the oil and gas industry in the United States, and internationally. It operates through Reservoir Description and Production Enhancement segments. The Reservoir Description segment includes the characterization of petroleum reservoir rock and reservoir fluid samples to enhance production and improve recovery of crude oil and gas from its clients' reservoirs.